Article
Comparison of the treatment efficacy between tigecycline plus high-dose cefoperazone-sulbactam and tigecycline monotherapy against ventilator-associated pneumonia caused by extensively drug-resistant Acinetobacter baumannii.
International journal of clinical pharmacology and therapeutics - 1 Mar 2018
Qin Youfa, Zhang Jie, Wu Lei, Zhang Dailong, Fu Lunjiao, Xue Xiaoyan
Abstract excerpt
OBJECTIVE: The present study examined the effect of high-dose cefoperazone-sulbactam combined with tigecycline against ventilator-associated pneumonia (VAP) caused by extensively drug-resistant Acinetobacter baumannii(XDR-AB). MATERIALS AND METHODS: 42 patients with VAP due to XDR-AB infection were randomized into two groups: the TIG group (received tigecycline injection) and the TIG+CFS group (received...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.